C07K 7/22
Tachykinins
Official title: {Tachykinins, e.g.} Eledoisins {, Substance P}; Related peptides
C07K7/22 (Tachykinins) appears on 104 US grants and 53 published applications in this corpus.
Search patents in C07K- Granted patents
- 104
- Published applications
- 53
- Assignees
- 72
- Inventors
- 189
- Latest grant
- 20 Dec 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 4 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 12 | 0 |
| 1999 | 6 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 4 |
| 2003 | 3 | 3 |
| 2004 | 3 | 4 |
| 2005 | 1 | 1 |
| 2006 | 2 | 8 |
| 2007 | 5 | 2 |
| 2008 | 5 | 5 |
| 2009 | 1 | 6 |
| 2010 | 7 | 2 |
| 2011 | 4 | 4 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 2 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Non-cleavable substance P conjugates and methods of use thereof20 Dec 2022US 11,530,243 B2Veiove Animal Health
- Substance P analog having progenitor cell or stem cell recruiting activity and method for progenitor cell or stem cell recruiting using the same30 Nov 2021US 11,186,612 B2Ajou University Industry-Academic Cooperation Foundation
- Antagonists of fish reproduction6 Oct 2020US 10,793,614 B2Yissum Research Development Company of the Hebrew University ofJerusaIem Ltd.
- Antagonists of neurokinin B in fish reproduction18 Dec 2018US 10,155,790 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Regulation of specific spinal neurons regulating pain transmission via chimeric toxins17 Jul 2018US 10,022,450 B2The Regents of the University of California
- Dual agonist glp-1 and neurotensin fusion peptide17 Apr 2025US 2025/0122239 A1
- Agonist of Tacr218 Apr 2024US 2024/0124524 A1University of Copenhagen
- Compounds and their use in treatment of tachykinin receptor mediated disorders21 Dec 2023US 2023/0406883 A1Embark Biotech ApS
- Non-cleavable substance p conjugates and methods of use thereof31 Aug 2023US 2023/0272008 A1Veiove Animal Health
- Dual agonist glp-1 and neurotensin fusion peptide24 Feb 2022US 2022/0056077 A1
Most cited
By later US patents
- Methods of producing nucleic acid ligands204US 5,595,877 ANeXstar Pharmaceuticals, Inc. · 1997
- Nucleic acid ligands to HIV-RT and HIV-1 rev178US 5,496,938 ANeXstar Pharmaceuticals, Inc. · 1996
- Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase152US 5,503,978 AUniversity Research Corporation · 1996
- Nucleic acid ligands of tissue target118US 6,127,119 ANeXstar Pharmaceuticals, Inc. · 2000
- Methods for identifying nucleic acid ligands of human neutrophil elastase115US 5,472,841 ANeXstar Pharmaceuticals, Inc. · 1995